Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/1/2025

Management of Gastrointestinal Sepsis

Immediate Recognition and Resuscitation

  • The World Journal of Emergency Surgery recommends early recognition and immediate initiation of resuscitation with crystalloid fluids, broad-spectrum antibiotics within 1 hour, and urgent source control within 12 hours for GI sepsis management, with careful attention to avoiding fluid overload that can worsen intra-abdominal hypertension 1, 2
  • Screen patients using qSOFA criteria: Glasgow Coma Scale ≤14, systolic blood pressure ≤100 mmHg, or respiratory rate ≥22/min indicate potential sepsis requiring urgent evaluation 2
  • Measure serum lactate immediately as part of initial assessment, though elevated lactate alone no longer defines sepsis 2
  • Calculate SOFA score to confirm organ dysfunction (increase of ≥2 points defines sepsis) 2
  • Administer 30 mL/kg of intravenous crystalloid fluid within the first 3 hours for sepsis-induced hypoperfusion 3
  • Use crystalloid solutions as first-line therapy because they are well-tolerated and cost-effective 1, 4, 5
  • Target mean arterial pressure (MAP) of 65-70 mmHg as the initial hemodynamic goal 1, 6, 7, 3

Antimicrobial Therapy

  • Administer empiric broad-spectrum intravenous antibiotics within 1 hour of sepsis recognition to cover all likely pathogens including gram-negative bacilli and anaerobes 3
  • Obtain blood cultures and other appropriate cultures before antibiotics if this causes no significant delay (<45 minutes) 3

Source Control

  • Identify and control the anatomical source of infection within 12 hours of diagnosis 5
  • Perform urgent surgical intervention for diffuse peritonitis, necrotizing soft tissue infection, intestinal perforation, or intestinal ischemia 5

Vasopressor Support

  • Use norepinephrine as first-line vasopressor if hypotension persists after initial fluid resuscitation 1, 7
  • Norepinephrine is more efficacious than dopamine for reversing hypotension in septic shock 1, 7

Supportive Care Specific to GI Sepsis

  • Implement bowel rest by restricting oral intake until bowel function returns 3
  • Place nasogastric tube for decompression if significant abdominal distention is present 3
  • Monitor for return of bowel sounds, passage of flatus, and bowel movements as signs of resolving ileus 3
  • Consider prokinetic agents once patient is stabilized and source control achieved 8, 3

Nutrition

  • Start enteral nutrition as soon as hemodynamically stable but withhold when patient requires significant vasopressor doses or when GI hypoperfusion is suspected 9
  • Consider parenteral nutrition only if ileus is prolonged (>5-7 days) 3
  • Avoid early parenteral nutrition in favor of early enteral feeding when GI tract is functional 9

Electrolyte and Metabolic Management

  • Correct electrolyte abnormalities, particularly potassium, magnesium, and phosphate 3
  • Monitor lactate levels and target normalization in patients with elevated levels 3

Monitoring and Reassessment

  • Perform regular clinical examinations multiple times daily to assess for improvement or deterioration 3
  • Monitor vital signs, urine output (target >0.5 mL/kg/h), and mental status continuously 3
  • Follow trends in inflammatory markers (C-reactive protein, procalcitonin) 3
  • Specifically monitor for abdominal compartment syndrome in patients with significant distention 8, 3

Additional Supportive Measures

  • Implement stress ulcer prophylaxis with proton pump inhibitors or H2-receptor antagonists in patients with risk factors for GI bleeding 9
  • Provide adequate pain control while minimizing opioids that worsen ileus 3
  • Implement early mobilization when hemodynamically stable to promote return of bowel function 3

What NOT to Do

  • Do not use hydroxyethyl starches for fluid resuscitation (associated with worse outcomes) 5
  • Do not follow rigid early goal-directed therapy protocols; recent trials (ProCESS, ARISE, ProMISe) show no mortality benefit over usual care 4, 7
  • Do not routinely use adjunctive therapies like polymyxin B hemoperfusion or blood purification techniques (insufficient evidence of benefit) 6, 8
  • Avoid forced abdominal closure in the presence of bowel edema and elevated intra-abdominal pressure 4, 7